EUS-guided drainage of large walled-off pancreatic necroses using plastic versus lumen-apposing metal stents: A single-centre randomised controlled trial
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
EUS-guided drainage of large walled-off pancreatic necroses using plastic versus lumen-apposing metal stents : A single-centre randomised controlled trial. / Karstensen, John Gásdal; Novovic, Srdan; Hansen, Erik Feldager; Jensen, Annette Bojer; Jorgensen, Henrik Lovendahl; Lauritsen, Morten Laksafoss; Werge, Mikkel Parsberg; Schmidt, Palle Nordblad.
In: Gut, Vol. 72, No. 6, 2023, p. 1167-1173.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - EUS-guided drainage of large walled-off pancreatic necroses using plastic versus lumen-apposing metal stents
T2 - A single-centre randomised controlled trial
AU - Karstensen, John Gásdal
AU - Novovic, Srdan
AU - Hansen, Erik Feldager
AU - Jensen, Annette Bojer
AU - Jorgensen, Henrik Lovendahl
AU - Lauritsen, Morten Laksafoss
AU - Werge, Mikkel Parsberg
AU - Schmidt, Palle Nordblad
N1 - Publisher Copyright: © 2022 Author(s). Published by BMJ.
PY - 2023
Y1 - 2023
N2 - Objective: In treating pancreatic walled-off necrosis (WON), lumen-apposing metal stents (LAMS) have not proven superior to the traditional double pigtail technique (DPT). Among patients with large WON (>15 cm) and their associated substantial risk of treatment failure, the increased drainage capacity of a novel 20-mm LAMS might improve clinical outcomes. Hence, we conducted a study comparing the DPT and 20-mm LAMS in patients with large WON. Design: A single-centre, open-label, randomised, controlled superiority trial using an endoscopic step-up approach in patients with WON exceeding 15 cm in size. The primary endpoint was the number of necrosectomies needed to achieve clinical success (clinical and CT resolution), while the secondary endpoints included technical success, adverse events, length of stay and mortality. Results: Twenty-two patients were included in the DPT group and 20 in the LAMS group, with no significant differences in patient characteristics. The median size of WON was 24.1 cm (P25-P75: 19.6-31.1). The technical success rates were 100% for DPT and 95% for LAMS (p=0.48), while clinical success rates were 95.5% and 94.7%, respectively (p=1.0). The mean number of necrosectomies was 2.2 for DPT and 3.2 for LAMS (p=0.42). Five patients (12%) developed procedure-related serious adverse events (DPT=4, LAMS=1, p=0.35). The median length of stay was 43 (P25-P75: 40-67) and 58 days (P25-P75: 40-86) in the DPT and LAMS groups (p=0.71), respectively, with an overall mortality of 4.8%. Conclusions: For treating large WON, LAMS are not superior to DPT. The techniques are associated with comparable needs for necrosectomy and hospital stay, and no gross difference in adverse events. Trial registration number: NCT04057846.
AB - Objective: In treating pancreatic walled-off necrosis (WON), lumen-apposing metal stents (LAMS) have not proven superior to the traditional double pigtail technique (DPT). Among patients with large WON (>15 cm) and their associated substantial risk of treatment failure, the increased drainage capacity of a novel 20-mm LAMS might improve clinical outcomes. Hence, we conducted a study comparing the DPT and 20-mm LAMS in patients with large WON. Design: A single-centre, open-label, randomised, controlled superiority trial using an endoscopic step-up approach in patients with WON exceeding 15 cm in size. The primary endpoint was the number of necrosectomies needed to achieve clinical success (clinical and CT resolution), while the secondary endpoints included technical success, adverse events, length of stay and mortality. Results: Twenty-two patients were included in the DPT group and 20 in the LAMS group, with no significant differences in patient characteristics. The median size of WON was 24.1 cm (P25-P75: 19.6-31.1). The technical success rates were 100% for DPT and 95% for LAMS (p=0.48), while clinical success rates were 95.5% and 94.7%, respectively (p=1.0). The mean number of necrosectomies was 2.2 for DPT and 3.2 for LAMS (p=0.42). Five patients (12%) developed procedure-related serious adverse events (DPT=4, LAMS=1, p=0.35). The median length of stay was 43 (P25-P75: 40-67) and 58 days (P25-P75: 40-86) in the DPT and LAMS groups (p=0.71), respectively, with an overall mortality of 4.8%. Conclusions: For treating large WON, LAMS are not superior to DPT. The techniques are associated with comparable needs for necrosectomy and hospital stay, and no gross difference in adverse events. Trial registration number: NCT04057846.
KW - acute pancreatitis
KW - endoscopic ultrasonography
U2 - 10.1136/gutjnl-2022-328225
DO - 10.1136/gutjnl-2022-328225
M3 - Journal article
C2 - 36446550
AN - SCOPUS:85144454400
VL - 72
SP - 1167
EP - 1173
JO - Gut
JF - Gut
SN - 0017-5749
IS - 6
ER -
ID: 332253049